
This pooled analysis assessed the safety of zzso in children with allergic zzso zzso zzso 

Two zzso zzso studies in children (6 to zzso zzso with zzso allergic asthma investigated the zzso of zzso Children on zzso asthma care zzso zzso controller zzso were zzso zzso to zzso zzso zzso zzso zzso or zzso zzso or zzso zzso safety findings from these trials are presented in this zzso 

The safety population included zzso children zzso zzso zzso zzso zzso events zzso were more frequently reported in the zzso zzso than zzso zzso zzso The most common zzso were zzso upper respiratory tract infection and zzso zzso zzso zzso included headache, zzso and zzso none of which were reported by zzso zzso of patients receiving zzso Serious zzso zzso were reported by zzso and zzso of patients receiving zzso and zzso zzso the most common were zzso pneumonia and zzso no deaths were zzso 

zzso has an acceptable safety profile, with a risk of zzso similar to zzso This, combined with its efficacy profile, suggests that zzso may provide an additional asthma management option for children (6 to zzso zzso uncontrolled with current therapy that follows established zzso 

